About Biomerica, Inc.
https://www.biomerica.comBiomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide.
CEO
Zackary S. Irani
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-04-21 | Reverse | 1:8 |
| 1994-11-14 | Reverse | 1:2 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
POTOMAC CAPITAL MANAGEMENT, INC.
Shares:167.7K
Value:$449.44K
BLACKROCK INC.
Shares:149.08K
Value:$399.54K
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.
Shares:14.5K
Value:$38.86K
Summary
Showing Top 3 of 5
About Biomerica, Inc.
https://www.biomerica.comBiomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $1.38M ▲ | $1.54M ▲ | $2K ▲ | 0.14% ▲ | $0 ▲ | $107K ▲ |
| Q4-2025 | $749K ▼ | $1.32M ▲ | $-1.54M ▼ | -206.14% ▼ | $-0.16 ▼ | $-1.46M ▼ |
| Q3-2025 | $1.12M ▼ | $1.23M ▼ | $-1.16M ▼ | -103.93% ▼ | $-0.07 ▼ | $-1.11M ▼ |
| Q2-2025 | $1.64M ▼ | $1.43M ▼ | $-950K ▲ | -58.07% ▲ | $-0.06 ▲ | $-993K ▲ |
| Q1-2025 | $1.81M | $1.66M | $-1.32M | -72.83% | $-0.08 | $-1.27M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $3.05M ▲ | $6.85M ▲ | $1.7M ▼ | $5.16M ▲ |
| Q4-2025 | $2.4M ▼ | $5.95M ▼ | $1.84M ▼ | $4.11M ▼ |
| Q3-2025 | $3.06M ▲ | $7.38M ▲ | $1.84M ▼ | $5.53M ▲ |
| Q2-2025 | $2.37M ▼ | $7.27M ▼ | $2.16M ▼ | $5.11M ▼ |
| Q1-2025 | $2.82M | $7.87M | $2.52M | $5.35M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $2K ▲ | $-268K ▲ | $-37K ▼ | $920K ▲ | $617K ▲ | $-268K ▲ |
| Q4-2025 | $-1.54M ▼ | $-661K ▲ | $4K ▲ | $-5K ▼ | $-658K ▼ | $-661K ▲ |
| Q3-2025 | $-1.16M ▼ | $-1.04M ▼ | $-4K ▲ | $1.74M ▲ | $686K ▲ | $-1.04M ▼ |
| Q2-2025 | $-950K ▲ | $-791K ▲ | $-33K ▲ | $380K ▲ | $-448K ▲ | $-791K ▲ |
| Q1-2025 | $-1.32M | $-1.34M | $-63K | $63K | $-1.35M | $-1.34M |
Revenue by Products
| Product | Q3-2022 | Q2-2022 | Q2-2024 | Q3-2024 |
|---|---|---|---|---|
 Clinical Lab | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Contract Manufacturing | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Physicians Office | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 ClinicalLabMember | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 ContractManufacturingMember | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 OverthecounterMember | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 PhysiciansOfficeMember | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q3-2023 | Q1-2026 |
|---|---|---|
 Asia | $0 ▲ | $0 ▲ |
 Europe | $0 ▲ | $0 ▲ |
 Middle East | $0 ▲ | $0 ▲ |
 North America | $0 ▲ | $0 ▲ |
 South America | $0 ▲ | $0 ▲ |
CEO
Zackary S. Irani
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-04-21 | Reverse | 1:8 |
| 1994-11-14 | Reverse | 1:2 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
POTOMAC CAPITAL MANAGEMENT, INC.
Shares:167.7K
Value:$449.44K
BLACKROCK INC.
Shares:149.08K
Value:$399.54K
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.
Shares:14.5K
Value:$38.86K
Summary
Showing Top 3 of 5